Business
Change of venue of General Meeting
Change of venue of General Meeting.
About this update from Edx Medical Group Plc
[{"type":"text","content":"\n\n \n \nChange of venue of General Meeting\nEDX Medical Group plc · EDX\n(\"EDX Medical\" or the \"Company\")\n \n18 October 2023\n \nFurther to the announcement on 2 October 2023, the Company announces it has changed the venue of the General Meeting on 25 October 2023 at 2:00 p.m. to Roosevelt Room, Brown's Hotel, 33 Albemarle Street, London W1S 4BP.\nExcept for the change of venue, no other changes had been made to the arrangements of the General Meeting.\n \nContacts:\n\n\n\n\nEDX Medical plc\n\n\n\n\n\n\n\n\nDr Mike Hudson (Chief Executive Officer)\n\n\n+44 (0)7812 345 301\[email protected]\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOberon Capital\n\n\n\n\n\n\n\n\nNick Lovering (Corporate Adviser)\nAdam Pollock (Corporate Broking)\nMike Seabrook (Corporate Broking)\n\n\n+44 (0)20 3179 5300\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nMedia House International\n\n\n\n\n\n\n\n\nRamsay Smith (Executive Director)\n \nGary McQueen (Associate Director)\n\n\n+44 (0)7788 414856\[email protected]\n+ 44 (0)7834 694609\[email protected]\n\n\n\n\n \nNotes for Editors:\nAbout EDX Medical Group\nwww.edxmedical.co.uk\nEDX Medical Group PLC develops innovative digital diagnostic products and services, enabling personalised treatment for cancer, heart disease and infectious diseases. The company is listed on the Access Segment of the AQSE Growth Market (TIDM: EDX).\nEDX Medical was founded by Professor Sir Christopher Evans, OBE, a medical and life sciences entrepreneur with more than 30 years of experience, together with CEO, Dr Mike Hudson.\nBy translating clinical insights into pragmatic solutions combining advanced biological and digital technologies, EDX Medical seeks to cost-effectively improve the detection and characterisation of disease in order to personalise treatment in a timely fashion. Early disease detection and biologically-based personal treatment optimisation is considered to be the most impactful way of reducing deaths and lowering the cost of healthcare globally.\nEDX Medical Group operates a molecular biology and diagnostics laboratory in Cambridge, UK, and 100%-owned subsidiary companies, Hutano Diagnostics Limited in Oxford, UK, and Torax Biosciences Ltd in Ireland. \nEDX Medical provides testing and genomic sequencing services, undertakes quality assurance, co...